Weil Conflict Tainted Insys Exec's Conviction, 1st Circ. Told

Law360 (September 23, 2020, 2:54 PM EDT) -- The former national sales director at Insys Therapeutics Inc. told the First Circuit on Wednesday that Weil Gotshal & Manges LLP's dual role representing both him in a criminal kickback trial and the company in its bankruptcy constitutes a "serious violation" of his rights.

Rich Simon argued to the appellate court that he should be cleared of the charges entirely, saying he had nothing to do with an Insys scheme to bribe doctors so they would prescribe the company's fentanyl spray and then lie to insurers so they would pay for the pricey drug.

At a minimum, Simon said he is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!